Hexamethyldisilazane (HMDS) Production Plant DPR & Unit Setup - 2026: Demand Analysis and Project Cost

Setting up a hexamethyldisilazane (HMDS) production plant positions investors at a critical junction of the global organosilicon specialty chemicals supply chain - one of the most strategically important and consistently expanding specialty chemical sectors - driven by the emerging shift toward high-purity electronic-grade chemicals, advanced packaging, microelectronics, and specialty silicone intermediates. The global hexamethyldisilazane (HMDS) market size was valued at USD 198.00 Million in 2025. The large and expanding base of semiconductor manufacturers, pharmaceutical and agrochemical API producers, specialty chemical formulators, coating and adhesive producers, and analytical laboratory operators worldwide require reliable regional supply of specification-grade HMDS meeting stringent purity, moisture, and chloride content requirements for photoresist adhesion promotion, silylating agent, surface hydrophobizing, and specialty organosilicon intermediate applications across all major consuming sectors.

Market Overview and Growth Potential:

The global hexamethyldisilazane (HMDS) market is driven by the emerging shift toward high-purity electronic-grade chemicals, advanced packaging, microelectronics, and specialty silicone intermediates. The global hexamethyldisilazane (HMDS) market size was valued at USD 198.00 Million in 2025. According to IMARC Group estimates, the market is expected to reach USD 357.94 Million by 2034, exhibiting a CAGR of 6.8% from 2026 to 2034. The Indian pharmaceutical market is a case in point; IBEF indicates that the market is slated to grow 7 to 9% in FY26 fueled by robust domestic demand, new product innovation and expansion into Europe, reflecting the scale of pharmaceutical sector expansion in India and similar emerging markets that is driving growing demand for HMDS as a critical silylating reagent and derivatization agent in pharmaceutical active ingredient synthesis and analytical chemistry applications. Demand is being strengthened by rising semiconductor fabrication activity, where HMDS improves photoresist adhesion and wafer surface hydrophobicity, enabling better lithography performance and defect control. Pharmaceutical and agrochemical manufacturers are also increasing consumption due to its use in synthesis, derivatization, and moisture-sensitive processing, while Asia Pacific is expected to remain a major demand hub due to electronics manufacturing, chemical production capacity, and expanding pharmaceutical output.

Request for Sample Report:https://www.imarcgroup.com/hexamethyldisilazane-manufacturing-plant-project-report/requestsample

Hexamethyldisilazane (HMDS) is an organosilicon compound and ammonia derivative widely used across multiple industries. In semiconductor manufacturing, it serves as a critical adhesion promoter, treating silicon wafers so photoresists bond securely during photolithography. In analytical chemistry, it is heavily relied upon to derivatize polar compounds, like alcohols and amino acids, making them volatile enough for gas chromatography. Additionally, HMDS is vital in organic synthesis as a silylating and protecting agent, and in nanotechnology for making surfaces hydrophobic. It is produced via reaction of trimethylchlorosilane with ammonia or lithium amide, followed by purification and distillation. Chemically, HMDS has a nitrogen atom bonded to two trimethylsilyl groups, enabling its versatile silyl transfer chemistry across diverse industrial and analytical applications. Its ability to create a highly uniform, moisture-resistant hydrophobic monomolecular layer on silicon oxide and other substrate surfaces makes it irreplaceable in semiconductor photolithography process flows.

The hexamethyldisilazane (HMDS) market outlook remains positive, supported by its expanding role as a high-performance silylation reagent, adhesion promoter, and surface treatment chemical across semiconductors, pharmaceuticals, coatings, and specialty materials. Demand is being strengthened by rising semiconductor fabrication activity and the continuous miniaturization of electronic devices requiring ever-more-precise photolithography adhesion performance. The expansion of global pharmaceutical manufacturing capacity and increasing analytical testing requirements in pharmaceutical quality control are providing sustained and growing demand for HMDS in synthesis and derivatization applications. Advancing nanotechnology and specialty coatings applications leveraging HMDS for superhydrophobic surface preparation and anti-reflective coating applications represent additional growth avenues beyond established core markets.

Plant Capacity and Production Scale:

The proposed hexamethyldisilazane (HMDS) production facility is designed with an annual production capacity of 3,000 MT, enabling economies of scale while maintaining operational flexibility across semiconductor-grade high-purity HMDS for photoresist adhesion promotion and silicon wafer surface treatment in microelectronics fabrication, pharmaceutical-grade HMDS for API synthesis silylation reagent and analytical derivatization applications, specialty silicone intermediate-grade HMDS for organosilicon polymer synthesis and surface modification agent production, coating and adhesive-grade HMDS for hydrophobic surface treatment and specialty adhesive promoter applications, and analytical laboratory-grade HMDS for gas chromatography derivatization and sample preparation applications across semiconductor manufacturing, pharmaceutical and analytical chemistry, silicone and specialty chemicals, coatings, adhesives and sealants, and lithium battery production end-use sectors. This production range supports supply to both large-scale semiconductor fabrication facility operators and pharmaceutical API manufacturers requiring continuous supply of specification-grade high-purity HMDS with full analytical certification, and specialty customers including nanotechnology material researchers and specialty coatings formulators requiring HMDS with verified ultra-low metal and halide impurity content.

Speak to an Analyst for Customized Report: https://www.imarcgroup.com/request?type=report&id=29356&flag=C

Financial Viability and Profitability Analysis:

The hexamethyldisilazane (HMDS) production business demonstrates healthy profitability potential under normal operating conditions. The financial projections reveal:

• Gross Profit: 28-36%

• Net Profit: 16-22%

These margins reflect the moisture-sensitive, high-purity synthesis and multi-stage purification nature of HMDS production, where trimethylchlorosilane and ammonia are processed through controlled reaction, ammonium chloride by-product filtration and removal, vacuum distillation, inhibitor addition, and sealed packaging operations to produce specification-grade HMDS meeting stringent purity, HCl content, color, and moisture specifications for semiconductor photolithography, pharmaceutical silylation, and analytical chemistry customer applications. Margins are supported by stable and growing demand from semiconductor and pharmaceutical sectors; growing semiconductor fabrication investment creating expanding photoresist adhesion promoter demand; the ability to command premium pricing for high-purity semiconductor-grade and pharmaceutical-grade HMDS with full analytical certification; and meaningful moisture-sensitive synthesis chemistry, high-purity process management, and customer qualification barriers to entry. The project demonstrates solid return on investment (ROI) potential with comprehensive financial analysis covering income projections, expenditure projections, break-even points, net present value (NPV), internal rate of return, and detailed profitability and sensitivity analysis. Trimethylchlorosilane procurement cost management and synthesis yield and distillation purity optimization are the primary operational variables impacting margin performance.

Cost of Setting Up a Hexamethyldisilazane (HMDS) Production Plant:

Operating Cost Structure:

The cost structure for a hexamethyldisilazane (HMDS) production plant is primarily driven by:

• Raw Materials: 55-65% of total OpEx

• Utilities: 9-13% of OpEx

• Other Expenses: Including transportation, packaging, salaries and wages, depreciation, taxes, and other expenses

Raw materials - particularly trimethylchlorosilane (TMCS) and ammonia - account for approximately 55-65% of total operating expenses, making trimethylchlorosilane procurement strategy, supplier qualification, purity specification management, and long-term supply contract management the central raw material cost management priority. TMCS purity, chlorine content, and moisture specification critically impact both the HMDS synthesis reaction yield and selectivity, and finished HMDS product purity, HCl content, and color quality, with raw material quality management directly affecting achievable product specification compliance for sensitive semiconductor and pharmaceutical application customers. Utilities represent 9-13% of OpEx, driven by the energy consumption of reaction vessel temperature control systems, vacuum distillation column reboiler and condenser energy requirements, inert atmosphere nitrogen purging and handling systems, and the temperature-controlled and moisture-excluded storage and packaging infrastructure required for HMDS product stability management throughout production and distribution. In the first year of operations, costs cover raw materials, utilities, depreciation, taxes, packing, transportation, and repairs and maintenance. By the fifth year, the total operational cost is expected to increase substantially due to factors such as inflation, market fluctuations, and potential rises in the cost of key materials, with supply chain disruptions, rising consumer demand, and shifts in the global economy also expected to contribute to this increase.

Capital Investment Requirements:

Setting up a hexamethyldisilazane (HMDS) production plant requires significant capital investment across reaction vessels, distillation columns, filtration units, purification systems, drying units, storage tanks, and sealed packaging infrastructure. The total capital investment depends on plant capacity, product purity grade mix, inert atmosphere handling capability, automation level, and location, covering land acquisition, site preparation, and specialty organosilicon chemical manufacturing infrastructure meeting all applicable chemical safety, moisture exclusion, and regulatory compliance requirements.

Land and Site Development: The location must offer easy access to key raw materials such as trimethylchlorosilane from certified organosilicon chemical manufacturers and ammonia from industrial gas or fertilizer chemical suppliers, along with proximity to target markets including semiconductor fabrication facilities, pharmaceutical API manufacturers, specialty chemical producers, analytical laboratory supply distributors, and coating and adhesive formulators to minimize transportation distances and logistics costs. The site must have robust infrastructure including reliable electrical power for reaction and distillation systems, moisture-excluded inert atmosphere production environment with nitrogen purging throughout HMDS handling and packaging areas, reliable road logistics access for raw material delivery and finished HMDS sealed container dispatch, and HCl scrubbing and ammonium chloride waste management systems for organosilicon chemical production environmental compliance. Compliance with specialty chemical manufacturing regulations, HCl and ammonia handling safety standards, moisture-sensitive organosilicon compound storage safety requirements, and all applicable worker safety and health regulations for chlorosilane and organosilicon compound exposure management must be ensured.

Machinery and Equipment: Equipment costs for reaction vessels, distillation columns, filtration units, purification systems, drying units, storage tanks, and packaging machines represent the largest capital expenditure category. High-quality, moisture-excluded, corrosion-resistant machinery tailored for HMDS production must be selected. Essential equipment includes:

• Reaction vessels - anhydrous, inert atmosphere jacketed stainless steel or glass-lined reactor vessels with temperature control, agitation, reflux condenser with HCl scrubber, and nitrogen purge systems for controlled reaction of trimethylchlorosilane with anhydrous ammonia or lithium amide at specified temperature and reactant ratio conditions to produce crude HMDS with ammonium chloride by-product in anhydrous reaction medium

• Filtration units - pressure or vacuum filtration systems with moisture-excluded anhydrous handling for separation of ammonium chloride salt by-product from crude HMDS liquid product, achieving efficient solid-liquid separation and recovery of clarified crude HMDS for downstream distillation purification

• Distillation columns - vacuum or atmospheric distillation column systems for purification of filtered crude HMDS by removal of residual trimethylchlorosilane, ammonia, silanol impurities, and higher-boiling organosilicon byproducts, achieving specification-grade HMDS purity, HCl content, color, and refractive index in distilled product with controlled anhydrous handling throughout distillation operations

• Purification systems - activated carbon adsorption or adsorbent bed treatment systems for color body and trace impurity removal from distilled HMDS, achieving ultra-low color (APHA) and trace metal ion content for semiconductor-grade and pharmaceutical-grade product quality compliance

• Drying units - molecular sieve drying systems for removal of trace moisture from finished HMDS product to specification water content below 50 ppm, preventing HMDS hydrolysis and product degradation during storage and transportation in moisture-sensitive semiconductor and analytical applications

• Storage tanks - nitrogen-blanketed, sealed stainless steel storage tanks with moisture exclusion desiccant breather systems for finished HMDS product inventory management, with continuous moisture and purity monitoring for product quality assurance during storage, and temperature management for product stability

• Packaging machines - automated sealed drum filling and cap torqueing systems with nitrogen purge for HMDS packaging in anhydrous sealed drums and carboys with moisture-barrier packaging for semiconductor and pharmaceutical customer delivery, together with weight verification and lot labeling with full analytical certificate documentation

All machinery must comply with applicable chemical processing equipment safety standards, chlorosilane and ammonia handling safety requirements, moisture-sensitive organosilicon compound production environment standards, and specialty chemical product quality standards. ISO 9001 quality management system certification, semiconductor-grade HMDS purity specification compliance with applicable SEMI standards for semiconductor process chemical purity, pharmaceutical-grade quality documentation for API synthesis and analytical application supply, and compliance with coating, adhesive, and specialty chemical customer technical specification and supplier qualification requirements are standard prerequisites for commercial HMDS supply to major semiconductor, pharmaceutical, analytical chemistry, and specialty chemical customers.

Civil Works: Building construction and plant layout optimized for efficient workflow, moisture-excluded production environment, and organosilicon specialty chemical manufacturing safety requirements across trimethylchlorosilane and ammonia raw material receiving and storage, anhydrous reaction area with HCl scrubbing, filtration and crude HMDS recovery, distillation and purification, molecular sieve drying, storage, sealed packaging, quality control laboratory, and dispatch areas. Fully enclosed and nitrogen-purged production environment throughout HMDS synthesis and handling areas for moisture exclusion, dedicated HCl scrubbing and neutralization systems for chlorosilane reaction by-product gas management, explosion-proof or appropriately classified electrical systems in ammonia handling areas, stainless steel or PTFE-lined product contact surfaces throughout for corrosion resistance and product purity protection, and dedicated quality control laboratory with Karl Fischer moisture analyzer, GC purity analysis, HCl titration, and APHA color measurement equipment are essential HMDS production facility safety, quality, and environmental compliance requirements.

Other Capital Costs: Costs associated with land acquisition, construction, and utilities including nitrogen generation or supply infrastructure for inert atmosphere purging throughout production, HCl scrubbing and neutralization systems for reaction off-gas treatment, vacuum generation system for distillation column operation, molecular sieve drying bed infrastructure for feedstock and product moisture removal, sealed and moisture-protected product storage area with desiccant climate control, sealed packaging equipment with nitrogen purge for anhydrous product delivery, and quality control laboratory with gas chromatography, Karl Fischer moisture analysis, and trace metal analysis capability must be considered in the financial plan. Pre-operative expenses including semiconductor chemical supplier qualification testing and documentation, pharmaceutical-grade quality documentation, ISO 9001 quality system certification, chemical manufacturing license and registration, environmental compliance approvals for HCl and ammonia emission management, initial trimethylchlorosilane and ammonia inventory for synthesis process development and product grade qualification, and operator organosilicon chemistry, chlorosilane safety, and moisture-sensitive handling training programs are important components of total project investment planning.

Buy Now: https://www.imarcgroup.com/checkout?id=29356&method=2175

Major Applications and Market Segments:

Hexamethyldisilazane (HMDS) production outputs serve critical adhesion promotion, silylation, surface modification, and derivatization functions across the global semiconductor, pharmaceutical, specialty chemicals, and analytical sectors:

Semiconductor Manufacturing: HMDS is used for photoresist adhesion promotion, wafer surface treatment, and moisture removal during microelectronics fabrication. As a photoresist adhesion promoter in semiconductor photolithography, HMDS vapor prime treatment of silicon wafer surfaces creates a uniform hydrophobic trimethylsilyl monolayer on the native silicon oxide surface that dramatically improves photoresist coating wettability, adhesion, and resistance to delamination during aqueous photoresist development, enabling finer photoresist feature resolution and defect-free pattern transfer critical for advanced node semiconductor device fabrication.

Pharmaceuticals: HMDS serves as a silylation reagent for synthesis of active pharmaceutical ingredients and specialty intermediates. In pharmaceutical synthesis, HMDS functions as a mild silylating agent for protection of reactive hydroxyl, carboxyl, and amine functional groups in multistep API synthesis, enabling selective chemical transformations on complex pharmaceutical molecules in the presence of sensitive functional groups that cannot tolerate more aggressive protecting group chemistry, with its dual silyl group transfer capability enabling efficient bis-silylation of diols and amino acids for pharmaceutical intermediate synthesis applications.

Silicones and Specialty Chemicals: HMDS is used in production of silicone compounds, organosilicon intermediates, and surface modification agents. As a silylating agent and silicone oligomer end-capper in organosilicon polymer synthesis, HMDS introduces trimethylsilyl end groups onto polydimethylsiloxane and specialty silicone polymer chains, controlling molecular weight and improving thermal stability of silicone intermediates. In surface modification chemistry, HMDS vapor treatment of inorganic fillers including precipitated silica, fumed silica, and mineral particles creates hydrophobic trimethylsilyl surface coatings that improve filler dispersion and reduce moisture sensitivity in silicone rubber, specialty coating, and polymer composite applications.

Analytical and Laboratory Applications: HMDS is used as a derivatization reagent for gas chromatography and sample preparation in analytical testing. In analytical chemistry, HMDS silylates polar analytes including alcohols, fatty acids, amino acids, steroids, carbohydrates, and other hydroxyl and carboxyl-containing compounds, converting them to volatile trimethylsilyl derivatives that are stable, symmetrical, and amenable to high-resolution gas chromatography and GC-mass spectrometry analysis for quantification and structural identification in pharmaceutical, food safety, environmental, and clinical diagnostic testing applications.

Why Invest in Hexamethyldisilazane (HMDS) Production?

Several compelling strategic and commercial factors make hexamethyldisilazane (HMDS) production an attractive investment:

Critical Specialty Chemical for Advanced Industries: Hexamethyldisilazane (HMDS) is a vital organosilicon compound widely used as a silylation agent, adhesion promoter, surface treatment chemical, and moisture scavenger across semiconductor manufacturing, pharmaceuticals, electronics, coatings, and specialty chemicals - positioning it as an essential material for high-performance industrial processes. The non-substitutable role of HMDS in semiconductor photolithography adhesion promotion, where no alternative chemical provides equivalent hydrophobic surface modification performance and process compatibility with semiconductor photoresist chemistries, creates structurally stable demand from the semiconductor sector regardless of economic cycles.

Moderate but Justifiable Entry Barriers: While production technology is well established, stringent purity requirements, moisture-sensitive handling, specialized reaction systems, quality assurance protocols, and customer qualification processes create meaningful barriers that favor technically capable manufacturers with strong process control and reliability. Semiconductor fab photoresist adhesion promoter qualification processes, pharmaceutical API synthesis supplier qualification requirements, and the long-term customer relationship management required for specialty organosilicon chemical supply create commercial barriers protecting established HMDS producers from rapid competitive displacement by technically unqualified new entrants.

Megatrend Alignment: Rapid growth in semiconductor fabrication, advanced electronics, pharmaceutical synthesis, specialty coatings, and silicon-based materials is driving sustained demand for HMDS. Expanding investments in chip manufacturing, digital infrastructure, and high-value chemical production are creating long-term growth opportunities for high-purity HMDS suppliers. The global semiconductor industry's sustained capital expenditure expansion in new wafer fabrication facilities, driven by demand for advanced logic chips, memory, and power semiconductors, creates structurally expanding HMDS consumption as each new fabrication facility requires photoresist adhesion promoter supply for ongoing production operations.

Policy and Industrial Development Support: Government initiatives promoting semiconductor self-sufficiency, electronics manufacturing, pharmaceutical production, and domestic specialty chemical capabilities - including programs such as Make in India and semiconductor incentive schemes - indirectly support demand for HMDS as a critical process chemical used across these strategic sectors. National semiconductor manufacturing investment programs in India, the European Union, the United States, Japan, and South Korea are creating expanding domestic semiconductor fabrication capacity that drives growing regional demand for locally sourced high-purity semiconductor process chemicals including HMDS.

Supply Chain Localization and Reliability: Semiconductor, pharmaceutical, and specialty chemical manufacturers increasingly seek dependable regional suppliers to reduce import dependence, shorten lead times, mitigate supply chain disruptions, and ensure consistent product quality, creating opportunities for domestic HMDS producers with strong technical expertise and secure raw material sourcing. The critical nature of HMDS in semiconductor photolithography process flows, where supply disruption can halt wafer fabrication production, creates strong incentives for semiconductor fabs to develop qualified regional HMDS supply relationships to reduce logistics risk and supply chain single-point-of-failure exposure.

Manufacturing Process Excellence:

The hexamethyldisilazane (HMDS) production process involves synthesis via reaction of trimethylchlorosilane with ammonia or lithium amide, followed by purification and distillation. The main production steps include:

• Raw material receiving and quality verification - trimethylchlorosilane (TMCS) and anhydrous ammonia incoming inspection for purity, moisture content, HCl content, and supplier certification verification per incoming quality control procedures and HMDS synthesis specification requirements, with all handling under strict anhydrous inert atmosphere conditions to prevent TMCS hydrolysis and product contamination

• Synthesis reaction - controlled anhydrous reaction of trimethylchlorosilane with excess anhydrous ammonia in inert atmosphere reactor at specified temperature and reactant ratio conditions, producing hexamethyldisilazane product with ammonium chloride salt by-product according to the reaction: 2 (CH3)3SiCl + NH3 → [(CH3)3Si]2NH + NH4Cl, with HCl scrubbing of reactor off-gas for ammonium chloride aerosol and unreacted ammonia management

• Ammonium chloride filtration - pressure or vacuum filtration of crude reaction mixture in anhydrous enclosed filtration equipment for separation of solid ammonium chloride salt by-product from liquid HMDS product, with washing of filter cake to maximize HMDS product recovery and minimize product loss in filter cake

• Vacuum distillation - controlled vacuum distillation of filtered crude HMDS for removal of residual trimethylchlorosilane, hexamethyldisiloxane impurity, and higher-boiling organosilicon byproducts from HMDS product fraction, achieving specification purity, HCl content, and refractive index in distilled HMDS product

• Purification and drying - activated carbon treatment for color body removal, followed by molecular sieve drying for reduction of trace water content to specification below 50 ppm to prevent product hydrolysis during storage and semiconductor wafer surface treatment application

• Quality testing - purity by gas chromatography, HCl content titration, water content by Karl Fischer titration, APHA color, refractive index, and trace metal content by ICP-MS for semiconductor-grade product specification compliance verification

• Packaging and dispatch - automated sealed drum filling with nitrogen purge, moisture-barrier container sealing, weight verification, lot labeling with full analytical certificate of analysis, and moisture-protected shipment packaging for anhydrous HMDS delivery to semiconductor, pharmaceutical, and specialty chemical customers

The complete process flow encompasses unit operations involved, mass balance and raw material requirements, quality assurance criteria, and technical tests throughout production. Reaction condition logs, filtration records, distillation operating parameter data, gas chromatography purity test results, Karl Fischer moisture content data, HCl titration records, trace metal analysis certificates for semiconductor-grade batches, and full material traceability from TMCS and ammonia raw material lot to finished HMDS production batch must be maintained throughout all production stages. Regular semiconductor fab process chemical qualification audits and pharmaceutical manufacturer supplier quality audit visits are standard operating requirements for commercial HMDS supply to major semiconductor, pharmaceutical, and specialty chemical customers.

Industry Leadership:

The global hexamethyldisilazane (HMDS) industry is served by major organosilicon specialty chemical producers with integrated trimethylchlorosilane supply chains and established customer relationships across semiconductor, pharmaceutical, and specialty chemical markets. Key industry players include:

• Wacker Chemie AG
• Evonik Industries AG
• Shin-Etsu Chemical Co., Ltd.
• Dow Corning Corporation
• Momentive Performance Materials

These companies serve diverse end-use sectors including semiconductor manufacturing, pharmaceuticals, specialty chemicals, coatings, adhesives, sealants, and lithium battery production, with leading players investing continuously in ultra-high-purity semiconductor-grade HMDS product development, moisture-sensitive handling and packaging capability, pharmaceutical-grade quality documentation, and production capacity expansion to meet the evolving purity, supply reliability, and certification requirements of global semiconductor fabrication, pharmaceutical synthesis, and specialty chemical customers.

Recent Industry Developments:

May 2025: A study published in the Journal of Scientific and Industrial Research presented a novel nano-silica-HMDS surface coating synthesized through an efficient chemical route, exhibiting anti-reflective, superhydrophobic, and anti-soiling properties suitable for solar panel top covers working in dusty environments. The synthesized surface coating enhances optical transmission, mitigating incident light reflection and performance loss from soiling. The experiment results showed a 5.8% average power improvement in the nano-silica-HMDS-coated solar photovoltaic cell compared to a manually cleaned, uncoated solar cell.

Browse Full Report: https://www.imarcgroup.com/hexamethyldisilazane-manufacturing-plant-project-report

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company excels in understanding its client's business priorities and delivering tailored solutions that drive meaningful outcomes. We provide a comprehensive suite of market entry and expansion services. Our offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: (+1-201-971-6302)

This release was published on openPR.